These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26583662)

  • 1. Long-term Results of Domino Liver Transplantation for Hepatocellular Carcinoma Using the "Double Piggy-back" Technique: A 13-Year Experience.
    Marques HP; Ribeiro V; Almeida T; Aniceto J; Silva S; Sobral M; Mateus É; Martins A; Barroso E
    Ann Surg; 2015 Nov; 262(5):749-56; discussion 756. PubMed ID: 26583662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
    Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
    JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
    Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
    Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma.
    Zheng Z; Lin B; Zhang J; Yang Z; Xie H; Zhou L; Zhang M; Zheng S
    J Gastroenterol Hepatol; 2015 Apr; 30(4):706-11. PubMed ID: 25238140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.
    Chua TC; Saxena A; Chu F; Morris DL
    Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.
    Canter RJ; Patel SA; Kennedy T; D'Angelica MI; Jarnagin WR; Fong Y; Blumgart LH; Freeman RB; DeMatteo RP; Abt PL
    Am J Clin Oncol; 2011 Oct; 34(5):466-71. PubMed ID: 20938319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
    Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
    Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
    An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.